Posted by: admin in ‘Pharmacy Drugs’ 16 October 2010 WASHINGTON – An FDA advisory panel today voted to recommend approval of GlaxoSmithKline‘s Cervarix vaccine for use against the two strains of human papillomavirus (HPV) that cause 70% of cervical cancers. In a separate action, the Vaccines and Related Biologics Committee recommended that the agency okay […]
Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18
Sholom Wacholder, study statistician and principal investigator1, Bingshu Eric Chen, assistant professor2, Allen Wilcox, senior investigator3, George Macones, professor of obstetrics and gynaecology4, Paula Gonzalez, study co-investigator5, Brian Befano, senior programmer6, Allan Hildesheim, study investigator, principal investigator1, Ana Cecilia Rodríguez, study co-investigator5, Diane Solomon, study co-investigator7, Rolando Herrero, study principal investigator5, Mark Schiffman, study co-investigator, […]
